Stone Paul A. 4
4 · IDEAYA Biosciences, Inc. · Filed Jun 19, 2020
Insider Transaction Report
Form 4
Stone Paul A.
SVP, General Counsel
Transactions
- Exercise/Conversion
Common Stock
2020-06-17$4.62/sh+3,100$14,322→ 18,100 total - Exercise/Conversion
Stock Option (right to buy)
2020-06-17−3,100→ 137,832 totalExercise: $4.62Exp: 2028-06-20→ Common Stock (3,100 underlying) - Sale
Common Stock
2020-06-17$17.50/sh−2,500$43,749→ 15,600 total - Sale
Common Stock
2020-06-17$19.95/sh−600$11,968→ 15,000 total
Footnotes (4)
- [F1]The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
- [F2]This transaction was executed in multiple trades in prices ranging from $17.48 to $17.74, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F3]This transaction was executed in multiple trades in prices ranging from $19.83 to $19.97, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F4]25% of the shares subject to the option vest on the first anniversary measured from May 2, 2018 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.